Toward Minimal Residual Disease-Directed Therapy in Melanoma
July 19, 2018, via Cell
New research in Cell tackles the biology of minimal residual disease (MRD) – the small number of cancer cells remaining after treatment – to identify key drivers of therapeutic resistance. Confocal imaging was performed using a Nikon A1 system.
